Business, energy, technology, markets and global industry news from Business News Today

Massive Bio

PharmaDeviceNews Massive Bio
Massive Bio expands Latin America oncology strategy through GELL research partnership
Pharma & Biotech

Can Massive Bio and GELL turn Latin America’s lymphoma research gaps into an AI-powered clinical trial advantage?

Massive Bio and GELL unite on oncology research, education and AI, but execution will determine whether the alliance expands trial access.

Read More
Representative image of an oncologist and clinical care team reviewing AI-powered cancer trial data, reflecting Massive Bio’s Reticulum Nexus push to improve oncology trial matching, biomarker reassessment and patient access after its ASCO 2026 product suite announcement.
Pharma & Biotech

How Massive Bio’s Reticulum Nexus suite is targeting the hidden bottlenecks in cancer trials

Can Massive Bio’s Reticulum Nexus suite close oncology trial access gaps? Find out how AI agents may reshape cancer trial navigation today!

Read More